Cardiology Atherosclerotic Cardiovascular Disease : Expert Discussion Dr. Thanassoulis & Dr. Lavoie — Length: 18:39 LDL-C Targets: Tackling Clinical Inertia and Nonadherence Watch Presentation
Cardiology Heart Failure: Expert Review and Commentary from Published Literature Dr. Kim Connelly and Dr. Michel White New Data Emphasize Prompt Initiation of ARNI Therapy as a Standard of Care for HFrEF in Patients With and Without Diabetes Download 6 PowerPoint slides
Cardiology Heart Failure: Expert Interview Dr. Kim Connelly — Length: 05:59 Prompt Initiation of ARNI Therapy in HFrEF Patients With or Without T2DM Watch Presentation
endocrinology Type 2 Diabetes: eLearning Program Dr. Ronald M. Goldenberg — Length: 29:36 The Role of DPP-4 Inhibitors in Type 2 Diabetes Watch Presentation
Cardiology European Society of Cardiology (ESC) Congress 2019 August 31 – September 4, 2019 — Paris, France Landmark DAPA-HF Trial: New Approach to Treatment of Heart Failure Download 4 PowerPoint slides
nephrology 2019 American Diabetes Association (ADA) 79th Scientific Sessions: Expert Interview Dr. Andrew Steele — Length: 04:40 Kidney Disease Prevention: New Findings from DECLARE-TIMI 58 Watch Presentation
nephrology 2019 American Diabetes Association (ADA) 79th Scientific Sessions June 7-11, 2019 — San Francisco, California SGLT-2 Inhibitor Decreases Renal Outcomes in Diabetic Patients without Baseline Renal Impairment Download 4 PowerPoint slides
Cardiology American College of Cardiology (ACC) 2019 Scientific Sessions March 16-18, 2019 — New Orleans, Louisiana DECLARE-TIMI 58 Sub-analyses: Expanding Evidence of Cardiovascular Protection across Broad Spectrum of Patients Download 5 PowerPoint slides
Cardiology American College of Cardiology (ACC) 2019 Scientific Sessions: Expert Interview Dr. Lawrence Leiter — Length: 08:19 DECLARE-TIMI 58 Subanalysis Expands Evidence of CV Benefits Watch Presentation
Cardiology American Heart Association (AHA) Scientific Sessions November 10-12, 2018 — Chicago, Illinois DECLARE-TIMI 58: Latest SGLT2 Cardiovascular Trial Supports Benefits beyond Glucose Control Download 4 PowerPoint slides
Cardiology American Heart Association (AHA) Scientific Sessions: Expert Interview Dr. Lawrence Leiter — Length: 10:21 DECLARE-TIMI 58: Benefits of SGLT2 Beyond Glucose Control Watch Presentation
Cardiology ACC.17: 66th Annual Scientific Session & Expo March 16-19, 2017 — Washington, DC Reduced All-Cause Death Suggests SGLT-2 Inhibitors May Be Part of New Anti-Diabetes Standard Download 6 PowerPoint slides